Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma
NCT02945319
·
clinicaltrials.gov ↗
COMPLETED
Status
373
Enrollment
OTHER
Sponsor class
Conditions
Splenic Marginal Zone Lymphoma
Sponsor
International Extranodal Lymphoma Study Group (IELSG)